Pain during sex (dyspareunia) is one of the most underreported symptoms of menopause. Surveys consistently find that fewer than a third of women experiencing it seek help, with shame, normalisation, and anticipated dismissal from clinicians cited as barriers.[1] Among those who do seek help, the most common response is advice to use lubricant, which addresses only one of several potential causes.

Dyspareunia in menopause is not a single problem. It encompasses at least four distinct presentations, each with its own mechanism, clinical assessment, and treatment approach. Treating one presentation when another is dominant produces no benefit and may cause harm.

Dryness and Tissue Atrophy (GSM)

Genitourinary syndrome of menopause (GSM) is the most common cause of dyspareunia at menopause. Estrogen maintains the thickness, elasticity, and lubrication capacity of vaginal tissue. As estrogen declines, tissue becomes thinner, less elastic, and produces less natural lubrication. Penetration against atrophied, dry tissue causes friction, microabrasions, and pain typically described as burning, rawness, or tearing during and immediately after sex.

Local vaginal estrogen (cream, pessary, or ring) is first-line treatment. Systemic HRT is an alternative for women with other menopausal symptoms also requiring treatment. Vaginal moisturisers used regularly (not just at sexual activity) help maintain tissue hydration. Lubricants reduce friction acutely but do not treat the underlying tissue change.

The key clinical marker: pain begins with penetration or friction and is located at the vaginal introitus or throughout the vaginal canal.

Hypertonic Pelvic Floor (Muscle-Based Dyspareunia)

Pelvic floor muscle dysfunction is one of the most commonly missed causes of dyspareunia. When these muscles are chronically tense (hypertonic), any attempt at penetration encounters a contracted muscular barrier. In its most complete form this is vaginismus: involuntary contraction that makes penetration impossible or severely painful.

Vaginismus and hypertonic dyspareunia can develop or worsen at menopause through several routes. Anticipatory anxiety about pain from prior GSM experiences creates a learned muscle-guarding response. Estrogen decline reduces muscle tissue quality and proprioception. Hypertonicity may also have pre-dated menopause and worsened with hormonal changes.

Lubricant does not address a hypertonic pelvic floor. Attempting penetration through contracted muscles causes pain regardless of lubrication. Topical estrogen alone does not resolve it either. Treatment is pelvic floor physiotherapy: a programme of progressive muscle relaxation and desensitisation, sometimes using graduated vaginal trainers under self-directed conditions.[2]

The key clinical marker: pain occurs before or at the point of penetration, associated with visible or palpable muscle contraction; a gripping or spasming quality at the vaginal entrance.

Deep Dyspareunia

Pain felt deep in the pelvis during penetration, rather than at the vaginal entrance, suggests pathology at the cervix, uterus, ovaries, or surrounding structures. Common causes include:

Endometriosis. Inflammatory lesions on peritoneal surfaces, ovarian endometriomas, and uterosacral ligament involvement all cause deep dyspareunia. Endometriosis can persist through perimenopause and may worsen with hormonal fluctuations. Women who had endometriosis in their reproductive years and experience worsening deep pain should have this evaluated, not attributed solely to menopause.

Ovarian cysts. Perimenopausal women can develop functional or pathological ovarian cysts that cause discomfort with deep penetration or certain positions. Any new deep dyspareunia warrants pelvic assessment to exclude ovarian pathology.

Uterine fibroid degeneration. Fibroids may shrink as estrogen falls postmenopause but can go through a phase of painful degeneration during perimenopause.

Bowel-related referred pain. The posterior vaginal wall is in close proximity to the rectum and sigmoid colon. Deep dyspareunia can be referred from bowel inflammation or spasm and is sometimes position-dependent.

The key clinical marker: pain is felt deep in the pelvis, often an aching or cramping pressure, and is position-dependent.

Vulvar Skin Conditions

Dyspareunia from vulvar skin disease is distinct from GSM, though the two can coexist.

Lichen sclerosus. An autoimmune skin condition causing thinning, whitening, and architectural distortion of the vulvar skin, including narrowing of the vaginal opening. It causes pain from inelasticity of affected skin, not dryness. Treatment is potent topical corticosteroids (clobetasol propionate), not estrogen. It is more common in postmenopausal women, and untreated lichen sclerosus carries a small increased long-term risk of vulvar squamous cell carcinoma.[3]

Lichen planus. A different inflammatory condition affecting the vaginal mucosa that can cause scarring, adhesions, and significant pain. Specialist dermatological or gynaecological assessment is required.

Contact dermatitis. Vulvar skin in postmenopause is thinner and more easily sensitised. Reactions to scented wipes, soaps, laundry detergents, and lubricants with additives can produce vulvar inflammation and dyspareunia, including to products previously tolerated.

The key clinical marker: visible skin changes on examination (whitening, thinning, architectural change, redness); pain worsened by any friction or contact with the affected area.

The Psychological Layer

Persistent pain creates anticipatory anxiety, avoidance behaviour, relationship tension, and loss of confidence in sexual identity. These are normal reactions to an aversive experience, but they can maintain the pain cycle even after the physical cause has been partly treated.

Psychosexual therapy (with a therapist trained specifically in sexual dysfunction rather than general relationship counselling) addresses the anxiety, avoidance, and relational dynamics that accumulate around painful sex. Evidence-based approaches include sensate focus (a graduated physical reconnection programme that bypasses performance anxiety around penetration), cognitive approaches to pain catastrophising, and specific communication frameworks for couples.[4]

Physical and psychological treatment combined consistently produces better outcomes than either alone.

Getting the Assessment Right

Because the causes of dyspareunia require different treatments, identifying which pattern is present (or which combination) is essential before starting treatment. A thorough assessment includes:

  • Clinical history asking about the character and location of pain (entrance versus deep, dryness-like versus gripping versus aching)
  • Genital examination assessing tissue quality, skin appearance, and pelvic floor tone
  • Questions about prior history (endometriosis, lichen sclerosus, pelvic floor problems)
  • Consideration of referral to a pelvic floor physiotherapist, a vulval specialist, or a gynaecologist with menopause expertise

A consultation that ends with advice to use lubricant, without examination and history-taking to determine which presentation is present, is an incomplete assessment.

The British Society for Sexual Medicine, the International Society for the Study of Vulvovaginal Disease (ISSVD), and NICE have all published guidance on the assessment and treatment of genitourinary and vulvar conditions contributing to dyspareunia. Women not receiving adequate care through primary care have the right to request a referral.

References

[1] Simon, J. A., Kokot-Kierepa, M., Goldstein, J., Nappi, R. E. (2013). Vaginal health in the United States: Results from the Vaginal Health: Insights, Views and Attitudes survey. Menopause, 20(10), 1043–1048. https://doi.org/10.1097/GME.0b013e318287342d

[2] Reissing, E. D., Brown, C., Lord, M. J., Binik, Y. M., Khalife, S. (2005). Pelvic floor muscle functioning in women with vulvar vestibulitis syndrome. Journal of Psychosomatic Obstetrics and Gynaecology, 26(2), 107–113. https://doi.org/10.1080/01443610400023106

[3] Bleeker, M. C., Visser, P. J., Overbeek, L. I., van Beurden, M., Berkhof, J. (2016). Lichen sclerosus: Incidence and risk of vulvar squamous cell carcinoma. Cancer Epidemiology, Biomarkers and Prevention, 25(8), 1224–1230. https://doi.org/10.1158/1055-9965.EPI-16-0019

[4] Brotto, L. A., Basson, R., Luria, M. (2008). A mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women. Journal of Sexual Medicine, 5(7), 1646–1659. https://doi.org/10.1111/j.1743-6109.2008.00850.x